{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:14:19Z","timestamp":1776071659845,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.msard.2020.102199","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T12:31:19Z","timestamp":1589891479000},"page":"102199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder."],"prefix":"10.1016","volume":"44","author":[{"given":"Marina A.","family":"Creed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Ballesteros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. John Greenfield","family":"Jr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2008-3133","authenticated-orcid":false,"given":"Jaime","family":"Imitola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.msard.2020.102199_bib0001","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.msard.2020.102199_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.msard.2020.102199_bib0003","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"13","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.msard.2020.102199_bib0004","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"issue":"Mar","key":"10.1016\/j.msard.2020.102199_bib0005","first-page":"1","article-title":"Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19","volume":"16","author":"Irani Thevarajan","year":"2020","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.msard.2020.102199_bib0006","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","article-title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia","volume":"221","author":"Wang","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.msard.2020.102199_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25819","article-title":"Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis","author":"Lagunas-Rangel","year":"2020","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.msard.2020.102199_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108413","article-title":"COVID-19 in a patient with long-term use of glucocorticoids: a study of a familial cluster","volume":"214","author":"Han","year":"2020","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.msard.2020.102199_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230177","article-title":"Brainstem encephalitis caused by Coxsackie A16 virus in a rituximab-immunosuppressed patient","volume":"12","author":"Cameron Smail","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.msard.2020.102199_bib0010","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1212\/WNL.0000000000007468","article-title":"Treatment of rituximab-associated chronic CNS enterovirus using IVIg and fluoxetine","volume":"92","author":"Sham","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102199_bib0011","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3201\/eid1908.130202","article-title":"Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012","volume":"19","author":"Kassab","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.msard.2020.102199_bib0012","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamaneurol.2018.0132","article-title":"Fatal powassan encephalitis (Deer Tick Virus, Lineage II) in a patient with fever and orchitis receiving rituximab","volume":"75","author":"Solomon","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2020.102199_bib0013","doi-asserted-by":"crossref","first-page":"ofx204","DOI":"10.1093\/ofid\/ofx204","article-title":"Two cases of severe tick-borne encephalitis in rituximab-treated patients in Germany: implications for diagnosis and prevention","volume":"4","author":"Steininger","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.msard.2020.102199_bib0014","doi-asserted-by":"crossref","first-page":"ofv136","DOI":"10.1093\/ofid\/ofv136","article-title":"West nile virus central nervous system infection in patients treated with rituximab: implications for diagnosis and prognosis, with a review of literature","volume":"2","author":"Morjaria","year":"2015","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.msard.2020.102199_bib0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/TCRM.S167109","article-title":"A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus","volume":"14","author":"Ishikawa","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.msard.2020.102199_bib0016","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s13365-018-0615-7","article-title":"Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event","volume":"24","author":"Berger","year":"2018","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.msard.2020.102199_bib0017","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/jamaneurol.2013.4668","article-title":"JC polyomavirus granule cell neuronopathy in a patient treated with rituximab","volume":"71","author":"Dang","year":"2014","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.msard.2020.102199_bib0018","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ijid.2020.03.062","article-title":"A first case of meningitis\/encephalitis associated with SARS-Coronavirus-2","volume":"94","author":"Moriguchi","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.msard.2020.102199_bib0019","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200537","article-title":"Forty years with coronaviruses","volume":"217","author":"Weiss","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.msard.2020.102199_bib0020","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3389\/fncel.2018.00386","article-title":"Neurologic alterations due to respiratory virus infections","volume":"12","author":"Bohmwald","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.msard.2020.102199_bib0021","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1182\/blood-2011-08-372649","article-title":"Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment","volume":"118","author":"Yri","year":"2011","journal-title":"Blood"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:54:52Z","timestamp":1761900892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820302753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":21,"alternative-id":["S2211034820302753"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102199","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mild COVID-19 infection despite chronic B cell depletion in a patient with aquaporin-4-positive neuromyelitis optica spectrum disorder.","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102199","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102199"}}